Blood Signals
Blood test has potential to detect earliest signals of Alzheimer’s … (News.Harvard.Edu)
Summary: A new study by Harvard-affiliated investigators at Mass General Brigham has found that a blood test for an Alzheimer’s disease biomarker, plasma phosphorylated tau 217 (pTau217), has the potential to predict progression of the illness years before symptoms or brain scan changes. The findings may help make disease prediction simpler and easier, and could indicate who may be at risk for cognitive decline. The results are published in Nature Communications.
Why it matters: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to track: A new study by Harvard-affiliated investigators at Mass General Brigham has found that a blood test for an Alzheimer’s disease biomarker, plasma phosphorylated tau 217 (pTau217), has the potential to predict progression of the illness years before symptoms or brain scan changes.
Context: A new study by Harvard-affiliated investigators at Mass General Brigham has found that a blood test for an Alzheimer’s disease biomarker, plasma phosphorylated tau 217 (pTau217), has the potential to predict progression of the illness years before symptoms or brain scan changes. The findings may help make disease prediction simpler and easier, and could indicate who may be at risk for cognitive decline. The results are published in Nature Communications.
"A new study by Harvard-affiliated investigators at Mass General Brigham has found that a blood test for an Alzheimer’s disease biomarker, plasma phosphorylated tau 217 (pTau217), has the potential to predict progression." — NEWS.HARVARD.EDU
Commentary: The immediate implication is operational rather than speculative: watch how this changes budgets, workflows, or risk assumptions over the next cycle.
Date: April 21, 2026 12:00 AM ET
URL: https://news.harvard.edu/gazette/story/2026/04/blood-test-has-potential-to-detect-earliest-signals-of-alzheimers-disease/
AI Sentiment Score: Negative (94%)
AI Credibility Score: 7.0/10 — Medium
Scores and text generated by AI analysis of the source article indicated.Blood Tests to Predict Risk of Alzheimer’s Disease-Yes, No, Maybe? (Drstreicher.Substack)
Summary: ##### Title: Patient views on blood-based biomarker tests for Alzheimer’s disease in primary care. ##### Link: Russell A, Vogeley A, Lovett R, O’Conor R, Batio S, Hurtado J, Bonham M, Benavente JY, Brickman AM, Williamson JD, Udeh-Momoh C, Mielke MM, Wolf M. Patient views on blood-based biomarker tests for Alzheimer’s disease in primary care.
Why it matters: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to track: ##### Title: Patient views on blood-based biomarker tests for Alzheimer’s disease in primary care.
Context: ##### Title: Patient views on blood-based biomarker tests for Alzheimer’s disease in primary care. ##### Link: Russell A, Vogeley A, Lovett R, O’Conor R, Batio S, Hurtado J, Bonham M, Benavente JY, Brickman AM, Williamson JD, Udeh-Momoh C, Mielke MM, Wolf M. Patient views on blood-based biomarker tests for Alzheimer’s disease in primary care.
"##### Title: Patient views on blood-based biomarker tests for Alzheimer’s disease in primary care. ##### Link: Russell A, Vogeley A, Lovett R, O’Conor R, Batio S, Hurtado J, Bonham M, Benavente JY,." — DRSTREICHER.SUBSTACK
Commentary: The immediate implication is operational rather than speculative: watch how this changes budgets, workflows, or risk assumptions over the next cycle.
Date: April 24, 2026 12:00 AM ET
URL: https://drstreicher.substack.com/p/blood-tests-to-predict-risk-of-alzheimers
AI Sentiment Score: Negative (80%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.Blood Tests Could Reveal Alzheimer’s Risk Years Before Symptoms … (Sciencealert)
Summary: A blood test shows significant promise for predicting the earliest stages of Alzheimer’s disease, even decades before symptoms show up. New research led by a team from Mass General Brigham in the US found that a blood biomarker called pTau217 could provide an early warning for potentially dangerous accumulations of amyloid-beta and tau proteins in the brain. A build-up of these proteins has long been associated with Alzheimer’s.
Why it matters: This matters for Alzheimer’s Disease and Frontal Temporal Dementia because it gives a concrete current signal to track: A blood test shows significant promise for predicting the earliest stages of Alzheimer’s disease, even decades before symptoms show up.
Context: A blood test shows significant promise for predicting the earliest stages of Alzheimer’s disease, even decades before symptoms show up. New research led by a team from Mass General Brigham in the US found that a blood biomarker called pTau217 could provide an early warning for potentially dangerous accumulations of amyloid-beta and tau proteins in the brain. A build-up of these proteins has long been associated with Alzheimer’s.
"A blood test shows significant promise for predicting the earliest stages of Alzheimer’s disease, even decades before symptoms show up. New research led by a team from Mass General Brigham in the." — SCIENCEALERT
Commentary: The immediate implication is operational rather than speculative: watch how this changes budgets, workflows, or risk assumptions over the next cycle.
Date: April 21, 2026 12:00 AM ET
URL: https://www.sciencealert.com/blood-tests-could-reveal-alzheimers-risk-years-before-symptoms-appear
AI Sentiment Score: Negative (64%)
AI Credibility Score: 10.0/10 — High
Scores and text generated by AI analysis of the source article indicated.Post ID: 2e41e28b